✦ LIBER ✦

PMH26 USING THE NET-BENEFIT REGRESSION APPROACH TO COMPARE THE COST-EFFECTIVENESS OF HALOPERIDOL, OLANZAPINE AND RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA

✍ Scribed by A De Ridder; D De Graeve

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH10 COST AND EFFECTIVENESS OF SWITCHIN

✍ NA Thomas; D Faries; H Ascher-Svanum; AW Nyhuis; BJ Kinon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PMH15 COST-EFFECTIVENESS OF AMISULPRID C

✍ E Kowalik; M Jakubczyk; J Lis; M Niewada 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Decision analysis model evaluating the c

✍ Mark Bounthavong; Mark P. Okamoto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

PMH3 A COST-EFFECTIVENESS COMPARISON OF

✍ S Beard; M Lothgren; L Giudi; F Ramacciotti; M Nardini; D Berardi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

The cost-analysis of olanzapine compared

✍ S. Almond; O. O'Donnell; J. McKendrick 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 276 KB

PMH15 COST-EFFECTIVENESS ANALYSIS OF LON

✍ A D'Ausilio; F Amaddeo; C Mencacci; C Munizza; H Miadi-Fargier; P Berto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB